Adial制药 ADIL 深 沪
等待开盘 05-20 09:30:00 美东时间
2.06
+0.450
+27.95%
华盛通- 最 高2.24
- 今 开1.64
- 成交量 177.81万股
- 最 低 1.64
- 昨 收 1.61
- 总市值 441.59万
- 52周最高 18.90
- 市盈率 静 --
- 换手率 82.95%
- 52周最低 1.31
- 委 比 -61.24%
- 总股本 214.36万
- 历史最高 5900.00
- 量 比 14.65
- 振 幅 37.27%
- 历史最低 1.64
- 每 手 1
- 风险率 4.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adial Pharmaceuticals Q1 EPS $(1.48) Beats $(2.73) Estimate
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(1.48) per share which beat the analyst consensus estimate of $(2.73) by 45.79 percent. This is a 82.59 percent increase over losses of $(8.50) per share
05-09 06:15
EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Disorder Drug
Adial Pharmaceuticals completes AD04 demo batch, validating process transfer and enabling Phase 3 production and FDA IND updates.
04-22 21:21
Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder
Adial backs H.R. 7091 targeting AUD in veterans, spotlighting harm reduction therapies and expanding research beyond abstinence-based care.
03-24 21:13
Adial Pharmaceuticals Q4 EPS $(11.48) Misses $(0.09) Estimate
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(11.48) per share which missed the analyst consensus estimate of $(0.09) by 12655.56 percent. This is a 206.13 percent decrease over losses of $(3.75) per
03-06 21:07
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million
Adial Pharma signs Europe deal with Molteni for AD04, eyeing up to $60 million in milestones and royalties.
03-03 21:02
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Super Micro Computer Inc (NASDAQ:SMCI) rose sharply in pre-market tra...
02-04 17:33
Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split, Effective Feb. 5
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,
02-04 05:23
Adial Pharmaceuticals Publishes International Patent Application For AD04 Serotonin-3 Receptor Antagonist Therapeutic Agent To Treat Alcohol Use Disorder
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,
01-14 22:03
Adial Pharmaceuticals announces immediate resignation of board director
Adial Pharmaceuticals ( ($ADIL) ) has issued an update. On January 5, 2025, Adi...
01-07 05:50
Adial Pharmaceuticals Secures $2.86M As Investor Exercises 9.2M Warrants At $0.31; Company To Issue 13.8M New Series F Warrants At Same Price
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today
2025-11-26 21:04
